Home / Business and Economy / Novartis India Profit Dips Amidst Sales Growth
Novartis India Profit Dips Amidst Sales Growth
12 May
Summary
- Novartis India's net profit fell 13.82% to Rs 25.25 crore in March 2026 quarter.
- Sales increased by 7.95% to Rs 90.55 crore in the same March 2026 quarter.
- Full-year net profit declined 7.65% to Rs 93.18 crore for the year ending March 2026.
In the quarter ending March 2026, Novartis India reported a 13.82% decrease in net profit, which amounted to Rs 25.25 crore. This figure compares to Rs 29.30 crore earned in the same period of the prior year. However, the company's sales showed positive movement, rising by 7.95% to reach Rs 90.55 crore during the March 2026 quarter, up from Rs 83.88 crore in the previous year.
Looking at the full fiscal year ending March 2026, Novartis India's financial performance indicated a decline in profitability. Net profit for the year was Rs 93.18 crore, a 7.65% drop from Rs 100.90 crore in the preceding fiscal year. Sales for the full year also experienced a minor decrease of 0.54%, totaling Rs 354.33 crore compared to Rs 356.27 crore.
The company's operational profit margin (OPM) for the March 2026 quarter was 22.77%, a decrease from 28.51% in the same quarter of the prior year. This trend was also observed in the profit before tax (PBT) and profit before depreciation and tax (PBDT) figures for both the quarterly and yearly periods, reflecting reduced profitability margins.
